A 40-year-old woman with a strong family history of breast cancer.
Garber
J
J
Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass, USA.
D000328:Adult; D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control* / Q000523:psychology; D003657:Decision Making; D005260:Female; D019398:Genes, BRCA1; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use; D014157:Transcription Factors / Q000235:genetics
D016588:Anticarcinogenic Agents; D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors; D013629:Tamoxifen